Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...

Peritoneal Dialysis I: Introduction and Procedure

Peritoneal Dialysis I: Introduction and Procedure

Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...

Peritoneal Dialysis III: Nursing Management

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...

Hemodialysis I: Introduction

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...

Dialysis

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Cardio-pulmonary-renal medicine].

Der Internist·2021

Same author

Advanced calibration kit for scanning microwave microscope: Design, fabrication, and measurement.

The Review of scientific instruments·2021

Same author

[Contrast medium-induced acute kidney injury-Consensus paper of the working group "Heart and Kidney" of the German Cardiac Society and the German Society of Nephrology].

Der Internist·2020

Same author

[Emerging zoonoses: Hantavirus infections].

Der nephrologe·2020

Same author

Consensus on definition and severity grading of lymphatic complications after kidney transplantation.

The British journal of surgery·2020

Same author

Effect of mycophenolic acid on inosine monophosphate dehydrogenase (IMPDH) activity in liver transplant patients.

Clinics and research in hepatology and gastroenterology·2020

Same journal

Proceedings of the 5th Annual UAB-UCSD O'Brien Center Symposium, March 4, San Diego, California.

Nephron. Clinical practice·2015

Same journal

Proceedings of the 19th International Conference on Continuous Renal Replacement Therapies, March 2-3, 2014, San Diego, California, USA.

Nephron. Clinical practice·2015

Same journal

Chronic kidney disease in disadvantaged populations.

Nephron. Clinical practice·2015

Same journal

Differential membrane expression of Toll-like receptors and intracellular cytokine induction in peripheral blood monocytes of patients with chronic kidney disease and diabetic nephropathy.

Nephron. Clinical practice·2015

Same journal

Correction of hyper- and hyponatraemia during continuous renal replacement therapy.

Nephron. Clinical practice·2015

Same journal

Ectopic expression of fatty acid-binding protein 4 in the glomerulus is associated with proteinuria and renal dysfunction.

Nephron. Clinical practice·2015

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 28, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

Continuous ambulatory peritoneal dialysis--developments during changing times.

J D Furkert¹, M Zeier, V Schwenger

¹Department of Nephrology and Gastroenterology, SLK-Kliniken Heilbronn, Heilbronn, Germany. juergen.furkert@slk-kliniken.de

Nephron. Clinical Practice

|October 22, 2008

Summary

This summary is machine-generated.

Continuous ambulatory peritoneal dialysis (CAPD) treatment has improved, with lower infection rates and better clinical parameters in recent years. This suggests enhanced medical care and the use of new dialysis fluids have positively impacted patient outcomes.

More Related Videos

Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion

Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion

Published on: May 23, 2025

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

Related Experiment Videos

Last Updated: Jun 28, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion

Laparoscopic-Assisted Seldinger Technique for Peritoneal Dialysis Catheter Insertion

Published on: May 23, 2025

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

Area of Science:

Nephrology
Internal Medicine
Clinical Research

Background:

Continuous ambulatory peritoneal dialysis (CAPD) is a dynamic treatment modality subject to ongoing evolution.
Changes in CAPD treatment require analysis of demographic, clinical, and infection-related data.
The Heidelberg outpatient clinic provides a setting to evaluate shifts in CAPD patient care.

Purpose of the Study:

To analyze changes in CAPD treatment at the Heidelberg outpatient clinic.
To compare demographic and clinical data of CAPD patients treated before and after the year 2000.
To assess trends in infection rates and clinical parameters over time.

Main Methods:

Retrospective study comparing two cohorts of CAPD patients.
Cohort 1: 67 patients treated before 2000. Cohort 2: 53 patients treated from 2000 onwards.
Data collected included demographics, CAPD-specific parameters, clinical data at treatment initiation, and during follow-up.

Main Results:

The more recent cohort (from 2000) was older (by 5 years) but presented with higher residual diuresis, lower blood pressure, and improved hemoglobin levels at treatment initiation.
Significant decrease observed in the incidence of peritonitis and exit-site infections in the recent cohort.
Hemoglobin levels showed an increase in patients treated from 2000 onwards.

Conclusions:

CAPD treatment parameters have demonstrably improved compared to previous periods.
Enhanced medical care, likely influenced by updated guidelines, contributes to better patient outcomes.
The adoption of new dialysis fluids is strongly associated with the significant reduction in infection rates.